Uncategorized
NovaBay reports $1.7 million loss in second quarter
NovaBay Pharmaceuticals reported a net loss of $1.7 million, or $0.11 per share, in the second quarter of 2017 compared with a net loss of $2.7 million, or $0.36 per share, in 2016’s second quarter. Net sales were up 55% from $2.7 million a year ago to $4.1 million in the second quarter, according to a press release.